Skip to main content

Advertisement

Log in

The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children’s Memorial Hospital

  • Invited Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Incidence

Worldwide, the incidence of neural tube defects (NTDs) varies from 0.17 to 6.39 per 1,000 live births. The declining prevalence of myelomeningocele, the most common NTD, is secondary to several factors including folic acid fortification, prenatal diagnosis with termination of affected fetuses, and unknown factors.

Impact of changes

Of those born with myelomeningocele, survival during infancy and preschool years has improved over the last 25 years (Bowman et al., Pediatr Neurosurg 34:114–120, 4). Fewer newborns today require shunt placement, which will hopefully improve the long-term mortality associated with this disease (Chakraborty et al., J Neurosurg Pediatr 1(5):361–365, 13, unpublished data). Of a cohort born in 1975–1979 and treated at a single US institution, 74% have survived into young adulthood.

Clinical implications

One of the greatest challenges facing these young adults is the transitioning of their medical care into an adult medical community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adzick NS, Sutton LN, Crombleholme TM, Flake AW (1998) Successful fetal surgery for spina bifida. Lancet 352:1675–1676

    Article  PubMed  CAS  Google Scholar 

  2. Blumenfeld Z, Siegler E, Bronstein M (1993) The early diagnosis of neural tube defects. Prenat Diagn 13:863–871

    Article  PubMed  CAS  Google Scholar 

  3. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens LM, McDonnell B, Merlob P, Ritvanen A, Scarano G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330(7491):571

    Article  PubMed  Google Scholar 

  4. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA (2001) Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 34:114–120

    Article  PubMed  CAS  Google Scholar 

  5. Busby A, Abramsky L, Dolk H, Armstrong B, Eurocat Folic Acid Working Group (2005) Preventing neural tube defects in Europe: population based study. BMJ 330(7491):574–575

    Article  PubMed  Google Scholar 

  6. Campbell J, Gilbert WM, Nicolaides KH, Campbell S (1987) Ultrasound screening for spina bifida: cranial and cerebellar signs in a high-risk population. Obstet Gynecol 70:247–250

    PubMed  CAS  Google Scholar 

  7. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F (1996) Hispanic origin and neural tube defects in Houston/Harris County. Texas. II. Risk factors. Am J Epidemiol 143:12

    PubMed  CAS  Google Scholar 

  8. Carmichael SL, Shaw GM, Song J, Abrams B (2008) Markers of acculturation and risk of NTDs among Hispanic women in California. Birth Defects Res A Clin Mol Teratol 82(11):755–762

    Article  PubMed  CAS  Google Scholar 

  9. Centers for Disease Control (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41(RR-14):1–7

    Google Scholar 

  10. Centers for Disease Control (2004) Spina bifida and anencephaly before and after folic acid mandate—United States, 1995–1996 and 1999–2000. MMWR Morb Mortal Wkly Rep 52:362–365

    Google Scholar 

  11. Centers for Disease Control (2008) Use of supplements containing folic acid among women of childbearing age—United States 2007. MMWR Morb Mortal Wkly Rep 57(1):5–8

    Google Scholar 

  12. Centers for Disease Control (2009) Racial/ethnic differences in the birth prevalence of spina bifida—United States, 1995–2005. MMWR Morb Mortal Wkly Rep 57(53):1409–1413

    Google Scholar 

  13. Chakraborty A, Crimmins D, Hayward R, Thompson D (2008) Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatr 1(5):361–365

    Article  PubMed  Google Scholar 

  14. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A (1993) Prevalence of neural tube defects in South Australia, 1966–91, effectiveness and impact on prenatal diagnosis. BMJ 307(6906):703–706

    Article  PubMed  CAS  Google Scholar 

  15. Chen CP (2008) Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects. Taiwan J Obstet Gynecol 47:283–290

    Article  PubMed  Google Scholar 

  16. Cowchock S, Ainbender E, Prescott G, Crandall B, Lau L, Heller R, Muir WA, Kloza E, Feigelson M, Mennuti M, Cederquist L (1980) The recurrence risk for neural tube defects in the United States: a collaborative study. Am J Med Genet 5:309–314

    Article  PubMed  CAS  Google Scholar 

  17. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319–324

    Article  PubMed  Google Scholar 

  18. Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, Speer MC, NTD Collaborative Group (2008) Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res A Clin Mol Teratol 82(10):662–9

    Article  PubMed  CAS  Google Scholar 

  19. Elwood JM, Elwood JH (1980) Epidemiology of anenecephalus and spina bifida. Oxford University Press, New York, Toronto, pp 85–119

    Google Scholar 

  20. Food and Drug Administration (1996) Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61:8781–8797

    Google Scholar 

  21. Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44(Suppl 3):4

    Article  PubMed  Google Scholar 

  22. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L (2008) Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health 99(4):271–275

    PubMed  Google Scholar 

  23. Golalipour MJ, Mobasheri E, Vakili MA, Keshtkar AA (2007) Epidemiology of neural tube defects in Northern Iran, 1998–2003. East Mediterr Health J 13(3):560–566

    PubMed  CAS  Google Scholar 

  24. Greene W, Terry R, Demasi R, Herrrington R (1991) Effect of race and gender on neurological level in myelomeningocele. Dev Med Child Neurol 33(2):110–117

    Article  PubMed  CAS  Google Scholar 

  25. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J (2002) Incidence of neural tube defects in Ontario, 1986–1999. Can Med Assoc J 167(3):237–240

    Google Scholar 

  26. Harmon JP, Hiett AK, Palmer CG, Golichowski AM (1980) Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Am J Med Genet 5:595

    Google Scholar 

  27. Harris MJ, Juriloff DM (2007) Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol 79:187–210

    Article  PubMed  CAS  Google Scholar 

  28. Hernandez-Dias S, Werler MM, Walker AM, Mitchell AA (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153(10):961–968

    Article  Google Scholar 

  29. Hunt GM, Oakeshott P (2003) Long-term outcome in open spina bifida. Br J Gen Pract 53(493):632–636

    PubMed  Google Scholar 

  30. Hunt GM, Oakeshott P (2003) Outcome in people with open spina bifida at age 35: prospective community based cohort study. BMJ 326(7403):1365–1366

    Article  PubMed  Google Scholar 

  31. Hunt G, Oakeshott P, Kerry S (1999) Link between the CSF shunt and achievement in adults with spina bifida. J Neurol Neurosurg Psychiatry 67(5):591–595

    Article  PubMed  CAS  Google Scholar 

  32. Johnson MP, Sutton LN, Rintoul N, Crombleholme TM, Flake AW, Howell LJ, Hedrick HL, Wilson RD (2003) Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 189:482–487

    Article  PubMed  Google Scholar 

  33. Jotkowitz AB, Glick S (2006) The Groningen protocol: another perspective. J Med Ethics 32:157

    Article  PubMed  CAS  Google Scholar 

  34. Kadir RA, Sabin C, Whitlow B, Brockbank E, Economides D (1999) Neural tube defects and periconception folic acid in England and Wales: retrospective study. BMJ 319:92–93

    PubMed  CAS  Google Scholar 

  35. Kaufman BA, Terbrock A, Winters N, Ito JA, Klosterman A, Park TS (1994) Disbanding a multidisciplinary clinic: effects on the healthy care of myelomeningocele patients. Pediatr Neurosurg 21:36–44

    Article  PubMed  CAS  Google Scholar 

  36. Kennedy D, Chitayat D, Winsor EJ, Silver M, Toi A (1998) Prenatally diagnosed neural tube defects: ultrasound, chromosome and autopsy or postnatal findings in 212 cases. Am J Med Genet 77:317

    Article  PubMed  CAS  Google Scholar 

  37. Kirke PN, Mills JL, Molloy AM, Brody LC, O’Leary VB, Daly L, Murray S, Conley M, Mayne PD, Smith O, Scott JM (2004) Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case control study. BMJ 328:1535–1536

    Article  PubMed  CAS  Google Scholar 

  38. Laurence K (1974) Effect of early surgery for spina bifida on survival and quality of life. Lancet 1:301–304

    Article  PubMed  CAS  Google Scholar 

  39. Leck I (1966) Changes in the incidence of neural-tube defects. Lancet 2:791–793

    Article  PubMed  CAS  Google Scholar 

  40. Lorber J (1973) Early results of selective treatment of spina bifida cystica. BMJ 4:201

    Article  PubMed  CAS  Google Scholar 

  41. Lorber J (1974) Selective treatment of myelomeningocele: to treat or not to treat? Pediatrics 53:307

    PubMed  CAS  Google Scholar 

  42. Lorber J, Salfield SA (1981) Results of selective treatment of spina bifida cystica. Arch Dis Child 56:822

    Article  PubMed  CAS  Google Scholar 

  43. Manninen BA (2006) A case for justified non-voluntary active euthanasia: exploring the ethics of the Groningen protocol. J Med Ethics 32:643

    Article  PubMed  CAS  Google Scholar 

  44. McLone DG (1983) Results of treatment of children born with a myelomeningocele. Clin Neurosurg 30:407–412

    PubMed  CAS  Google Scholar 

  45. McLone DG (1986) Treatment of myelomeningocele: arguments against selection. Clin Neurosurg 33:359–370

    PubMed  CAS  Google Scholar 

  46. McLone DG (1986) The diagnosis, prognosis and outcome for the handicapped newborn: a neonatal view. Issues Law Med 2:15

    PubMed  CAS  Google Scholar 

  47. McLone DG (1989) Spina bifida today: problems adults face. Semin Neurol 9(3):169–175

    Article  PubMed  CAS  Google Scholar 

  48. McLone DG (2008) Deliberate termination of life of newborns with spina bifida. Childs Nerv Syst 24:33

    Article  Google Scholar 

  49. McLone DG, Dias L, Kaplan WE, Sommers MW (1985) Concepts in the management of spina bifida. In: Humphreys RP (ed) Concepts in Pediatric Neurosurgery, vol 5. Karger, Basel, pp 97–106

    Google Scholar 

  50. Medical Research Council Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131–137

    Article  Google Scholar 

  51. Moretti MD, Bar-Oz B, Fried S, Koren G (2005) Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 16:216

    Article  PubMed  Google Scholar 

  52. Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, Werler MM, Hobbs CA (2009) Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 169(1):9–17

    Article  PubMed  Google Scholar 

  53. Papp C, Adam Z, Toth-Pal E, Török O, Váradi V, Papp Z (1997) Risk of recurrence of craniospinal anomalies. J Matern Fetal Med 6:57

    Article  Google Scholar 

  54. Persad VL, Van den Hof MC, Dube JM, Zimmer P (2002) Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 167(3):241–245

    PubMed  Google Scholar 

  55. Sawyer SM, Collins N, Bryan D, Brown D, Hope MA, Bowes G (1998) Young people with spina bifida: transfer from paediatric to adult health care. J Paediatr Child Health 34(5):414–417

    Article  PubMed  CAS  Google Scholar 

  56. Shaer CM, Chescheir N, Schulkin J (2007) Myelomeningocele: a review of the epidemiology, genetics, risk factors for conception, prenatal diagnosis and prognosis for affected individuals. Obstet Gynecol 62(7):471–479

    Google Scholar 

  57. Shurtleff DB (2004) Epidemiology of neural tube defects and folic acid. Cerebrospinal Fluid Res 1:5–9

    Article  PubMed  Google Scholar 

  58. Sutton LN (2008) Fetal surgery for neural tube defects. Best Pract Res Clin Obstet Gynaecol 22:175

    Article  PubMed  Google Scholar 

  59. Tulipan N, Bruner JP (1998) Myelomeningocele repair in utero: a report of three cases. Pediatr Neurosurg 28:177

    Article  PubMed  CAS  Google Scholar 

  60. Verhagen AA, Sauer PJ (2005) The Groningen protocol—euthanasia in severely ill newborns. N Engl J Med 352:959

    Article  PubMed  CAS  Google Scholar 

  61. Verhagen AA, Sol JJ, Brouwer OF, Sauer PJ (2005) Deliberate termination of life in newborns in the Netherlands: review of all 22 reported cases between 1997 and 2004. Ned Tijdschr Geneeskd 149:183

    PubMed  CAS  Google Scholar 

  62. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD (2005) Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics 116:580–586

    Article  PubMed  Google Scholar 

  63. Woodhouse CRJ (2008) Myelomeningocele: neglected aspects. Pediatr Nephrol 23(8):1223–1231

    Article  PubMed  Google Scholar 

  64. Zheng XY, Song XM, Chen G, Ji Y, Wu JL, Liu JF, Zhang L, Fan XH (2007) Epidemiology of birth defects in high-prevalence areas of China. Zhonghua Liu Xing Bing Xue Za Zhi 28:5–9

    PubMed  CAS  Google Scholar 

  65. Zlotogora J, Amitai Y, Leventhal A (2006) Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid. Isr Med Assoc J 8(9):601–604

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robin M. Bowman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowman, R.M., Boshnjaku, V. & McLone, D.G. The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children’s Memorial Hospital. Childs Nerv Syst 25, 801–806 (2009). https://doi.org/10.1007/s00381-009-0865-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-009-0865-z

Keywords

Navigation